Company / SG&A per Share
Annovis Bio, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.32
FY2025
5-year range
$0.32 / $1.11
FY2021-FY2025
Trend
-46.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 3 consecutive years, from $1.11 in FY2022 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of -35.9%.
Improved from $1.10 to $0.32 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -34.2%
- 5-Year CAGR
- -35.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Annovis Bio, Inc.'s sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 46.6% year-over-year.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | -46.6% |
| FY2024 | $0.59 | -46.1% |
| FY2023 | $1.10 | -0.8% |
| FY2022 | $1.11 | +113.4% |
| FY2021 | $0.52 | -82.3% |
| FY2020 | $2.93 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026